| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Nov 30, 2022 | Dec 2, 2022 | Xos, Inc. | Director | Buy | 95.0 | +300,000 | 54.70% | ✗ | $207K |
| Nov 18, 2021 | Nov 22, 2021 | Xos, Inc. | Director | Buy | 97.5 | +100,000 | 42.52% | ✗ | $426.8K |
| Sep 1, 2021 | Sep 2, 2021 | Xos, Inc. | Director | Buy | 78.8 | +5,000 | 2.17% | ✗ | $33.3K |
| Mar 3, 2020 | Mar 4, 2020 | AbbVie Inc. | Director | Buy | 97.5 | +2,875 | 100.00% | ✗ | $252.6K |
| Jun 26, 2019 | Jun 28, 2019 | AbbVie Inc. | Director | Buy | 97.5 | +7,500 | 32.38% | ✗ | $504.8K |
| Jun 20, 2018 | Jun 22, 2018 | AbbVie Inc. | Director | Buy | 90.0 | +1,013 | 5.13% | ✗ | $99.9K |
| Jul 31, 2017 | Aug 2, 2017 | AbbVie Inc. | Director | Buy | 97.5 | +4,000 | 34.79% | ✗ | $281.8K |